SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-11-031493
Filing Date
2011-05-20
Accepted
2011-05-20 17:05:19
Documents
5
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 v223597_10q.htm 10-Q 473204
2 v223597_ex31-1.htm EX-31.1 16359
3 v223597_ex31-2.htm EX-31.2 16694
4 v223597_ex32-1.htm EX-32.1 8149
5 v223597_ex32-2.htm EX-32.2 8513
  Complete submission text file 0001144204-11-031493.txt   524045
Mailing Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266
Business Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266 866-963-2220
Genesis Biopharma, Inc (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-53127 | Film No.: 11862360
SIC: 4731 Arrangement of Transportation of Freight & Cargo